{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:09:16Z","timestamp":1789913356900,"version":"4.0.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,10,12]],"date-time":"2010-10-12T00:00:00Z","timestamp":1286841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00192-010-1294-y","type":"journal-article","created":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T00:18:58Z","timestamp":1287015538000},"page":"401-405","source":"Crossref","is-referenced-by-count":81,"title":["Long-term results of intravesical hyaluronan therapy in bladder pain syndrome\/interstitial cystitis"],"prefix":"10.1007","volume":"22","author":[{"given":"Paul F.","family":"Engelhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nike","family":"Morakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas K.","family":"Daha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Esterbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus R.","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,12]]},"reference":[{"key":"1294_CR1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.mou.0000232048.81965.16","volume":"16","author":"BR Toft","year":"2006","unstructured":"Toft BR, Nordling J (2006) Recent developments of intravesical therapy of painful bladder syndrome\/interstitial cystitis: a review. Curr Opin Urol 16:268\u2013272","journal-title":"Curr Opin Urol"},{"key":"1294_CR2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-5347(01)65933-0","volume":"156","author":"A Morales","year":"1996","unstructured":"Morales A, Emerson L, Nickel JC, Lundie M (1996) Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol 156:45\u201348","journal-title":"J Urol"},{"key":"1294_CR3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eururo.2008.03.086","volume":"54","author":"M Fall","year":"2008","unstructured":"Fall M, Oberpenning F, Peeker R (2008) Treatment of bladder pain syndrome\/interstitial cystitis 2008: can we make evidence-based decisions? Eur Urol 54:65\u201378","journal-title":"Eur Urol"},{"key":"1294_CR4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000283012","volume":"59","author":"D Porru","year":"1997","unstructured":"Porru D, Campus G, Tudino D, Valdes E, Vespa A, Scarpa RM, Usai E (1997) Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid. Urol Int 59:26\u201329","journal-title":"Urol Int"},{"key":"1294_CR5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1464-410X.1997.03384.x","volume":"79","author":"JJ Bade","year":"1997","unstructured":"Bade JJ, Laseur M, Nieuwenburg A, van der Weele LT, Mensink HJ (1997) A placebo controlled study of intravesical pentosanpolysulfate for the treatment of interstitial cystitis. Br J Urol 79:168\u2013171","journal-title":"Br J Urol"},{"key":"1294_CR6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1464-410X.1994.tb07634.x","volume":"73","author":"CL Parsons","year":"1994","unstructured":"Parsons CL, Housley T, Schmidt JD, Lebow D (1994) Treatment of interstitial cystitis with intravesical heparin. Br J Urol 73:504\u2013507","journal-title":"Br J Urol"},{"key":"1294_CR7","first-page":"1454","volume":"9","author":"G Steinhoff","year":"2002","unstructured":"Steinhoff G, Ittah B, Rowan S (2002) The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can J Urol 9:1454\u20131458","journal-title":"Can J Urol"},{"issue":"1","key":"1294_CR8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1464-410X.2008.08028.x","volume":"103","author":"JC Nickel","year":"2009","unstructured":"Nickel JC, Egerdie B, Downey J, Singh R, Skehan A, Carr L, Irvine-Bird K (2009) A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis. BJU Int 103(1):56\u201360","journal-title":"BJU Int"},{"issue":"5","key":"1294_CR9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00192-007-0515-5","volume":"19","author":"CR Riedl","year":"2008","unstructured":"Riedl CR, Engelhardt PF, Daha KL, Morakis N, Pfl\u00fcger H (2008) Hyaluronan treatment of interstitial cystitis\/painful bladder syndrome. Int Urogyneocol J Pelvic Floor Dysfunct 19(5):717\u2013721","journal-title":"Int Urogyneocol J Pelvic Floor Dysfunct"},{"key":"1294_CR10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/00365590410015876","volume":"39","author":"EB Kallestrup","year":"2005","unstructured":"Kallestrup EB, Steinunn S, J\u00f8rgense S, Nordling J, Hald T (2005) Treatment of interstitial cystitis with Cystistat\u00ae: a hyaluronic acid product. Scand J Urol Nephrol 39:143\u2013147","journal-title":"Scand J Urol Nephrol"},{"key":"1294_CR11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.ju.0000081163.46167.82","volume":"170","author":"LK Daha","year":"2003","unstructured":"Daha LK, Riedl CR, Hohlbrugger G, Knoll M, Engelhardt PF, Pfluger H (2003) Comparative assessment of maximal bladder capacity, 0.9% NaCL versus 0.2M KCl, for the diagnosis of interstitial cystitis: a prospective controlled study. J Urol 170:807\u2013809","journal-title":"J Urol"},{"key":"1294_CR12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00182044","volume":"12","author":"RE Hurst","year":"1994","unstructured":"Hurst RE (1994) Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract. World J Urol 12:3\u201310","journal-title":"World J Urol"},{"key":"1294_CR13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0090-4295(02)01613-8","volume":"60","author":"M Leppilahti","year":"2002","unstructured":"Leppilahti M, Hellstr\u00f6m P, Tammela TLJ (2002) Effect of diagnostic hydrodistension and four intravesical Hyaluronan Instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis. Urology 60:46\u201351","journal-title":"Urology"},{"issue":"2","key":"1294_CR14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-0028-1098784","volume":"40","author":"A Schulz","year":"2009","unstructured":"Schulz A, Vestweber AM, Dressler D (2009) Anti-inflammatory action of a hyaluronic acid-chondroitin sulphate preparation in an in vitro bladder model. Akt Urol 40(2):109\u2013112","journal-title":"Akt Urol"},{"key":"1294_CR15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0090-4295(01)01586-2","volume":"59","author":"CL Parsons","year":"2002","unstructured":"Parsons CL, Forrest J, CJ CJ, the Elmiron Study Group (2002) Effect of pentosan polysulfate therapy on intravesical potassium sensitivity. Urology 59:329\u2013334","journal-title":"Urology"},{"key":"1294_CR16","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1464-410X.2005.05776.x","volume":"96","author":"SK Gupta","year":"2005","unstructured":"Gupta SK, Pidcock L, Parr NJ (2005) The potassium sensitivity test: a predictor of treatment response in interstitial cystitis. BJU Int 96:1063\u20131066","journal-title":"BJU Int"},{"key":"1294_CR17","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0022-5347(05)68801-5","volume":"161","author":"JM Teichman","year":"1999","unstructured":"Teichman JM, Nielsen-Omeis BJ (1999) Potassium leak test predicts outcome in interstitial cystitis. J Urol 161:1791\u20131796","journal-title":"J Urol"},{"issue":"4","key":"1294_CR18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/00365590701871518","volume":"42","author":"L Daha","year":"2008","unstructured":"Daha L, Riedl CR, Lazar D, Simak R, Pfl\u00fcger H (2008) Effect of intravesical glycosaminoglycan substitution therapy on bladder pain syndrome\/interstitial cystitis, bladder capacity and potassium sensitivity. Scand J Urol 42(4):369\u2013372","journal-title":"Scand J Urol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-010-1294-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-010-1294-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-010-1294-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T10:51:04Z","timestamp":1558608664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-010-1294-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,12]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["1294"],"URL":"https:\/\/doi.org\/10.1007\/s00192-010-1294-y","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,12]]}}}